Noble Bio Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 13.23%
- Profit Growth 28.03%
- Ebitda 28.02%
- Net Worth -25.12%
- Total Assets 2.54%
About Noble Bio Sciences
Noble Bio Sciences Private Limited (NBSPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 March 2016 (Eight years and ten months 9 days old ). Its registered office is in Krishna, Andhra Pradesh, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Syamkumar Chunduru and Rajani Talakayala serve as directors at the Company.
Company Details
-
Location
Krishna, Andhra Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U05004AP2016PTC098601
-
Company No.
098601
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Mar 2016
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Vijayawada
Industry
Who are the key members and board of directors at Noble Bio Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Syamkumar Chunduru
|
Director | 08-Mar-2018 | Current |
|
Rajani Talakayala
|
Director | 24-Mar-2016 | Current |
Financial Performance of Noble Bio Sciences.
Noble Bio Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 13.23% increase. The company also saw a substantial improvement in profitability, with a 28.03% increase in profit. The company's net worth observed a substantial decline by a decrease of 25.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Noble Bio Sciences?
In 2021, Noble Bio Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
-
Indian Institute Of Politics Private Limited
Rajani Talakayala is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Noble Bio Sciences?
Unlock and access historical data on people associated with Noble Bio Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Noble Bio Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Noble Bio Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
